FilingReader Intelligence
Huahai Pharma proceeds with private share placement, subsidiary boost
March 27, 2025 at 08:55 PM UTC•By FilingReader AI
Zhejiang Huahai Pharmaceutical (SSE: 600521) is moving forward with its plans for strategic growth, executing a private placement of shares and injecting capital into its subsidiary, Huahai Pharmaceutical Technology.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Zhejiang Huahai Pharmaceutical Co., Ltd.'s announcement on using raised funds to increase capital in subsidiaries to implement fundraising projectsMarch 20, 2025 at 10:49 AM UTC
Zhejiang Huahai Pharmaceutical Co., Ltd.'s announcement on using raised funds to replace self-raised funds previously invested in fundraising projects and paid for issuance expensesMarch 20, 2025 at 10:49 AM UTC
Zhejiang Huahai Pharmaceutical Co., Ltd.'s Report on Issuance of Shares to Specific TargetsMarch 20, 2025 at 10:49 AM UTC
News Alerts
Get instant email alerts when Zhejiang Huahai Pharmaceutical publishes news
Free account required • Unsubscribe anytime